Protalix BioTherapeutics, Inc. Operating Lease Right-of-Use Assets
Protalix BioTherapeutics, Inc. (PLX) had Operating Lease Right-of-Use Assets of $8.18 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-12
- 2026-06-30: Operating Lease, Right-of-Use Asset $8.18M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $7.79M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $7.70M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $7.81M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $8.18M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $7.79M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $7.70M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $7.81M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $5.00M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $5.22M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $5.43M 10-K · filed 2026-03-18 |
| 2024-09-30 | $5.64M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $5.73M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $5.88M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $5.91M 10-K · filed 2025-03-17 |
| 2023-09-30 | $5.92M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $5.81M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $5.20M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $5.09M 10-K · filed 2024-03-14 |
| 2022-09-30 | $4.85M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $4.77M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $4.90M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $4.96M 10-K · filed 2023-02-27 |
| 2021-09-30 | $5.25M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $5.41M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $5.49M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $5.57M 10-K · filed 2022-03-31 |
| 2020-09-30 | $5.70M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $5.68M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $5.71M 10-Q · filed 2020-06-01 |
| 2019-12-31 | $5.68M 10-K · filed 2021-03-30 |
| 2019-09-30 | $5.76M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $5.86M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $5.84M 10-Q · filed 2019-05-06 |
| 2019-01-01 | $5.90M 10-K · filed 2020-03-12 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |